Partnering with eye care professionals to redefine what’s possible
At Tenpoint Therapeutics™, we’re rejuvenating vision for the aging eye. By understanding real-world needs and partnering with eye care professionals, we’re setting a new standard for presbyopia care.
Presbyopia is just the beginning
Presbyopiais a gradual loss of near visual acuity that typically begins around the age 50 and significantly affects aging eyes and may significantly affect quality of life if left uncorrected.1-3
We’re prioritizing:
Functional near visionto address real-world needs
Functional near visionto address real-world needs
Presbyopia affects people daily, making it difficult to read and manage work or social activities.2,4
Tenpoint Therapeutics™ is transforming the treatment landscape by confronting the unmet needs that millions of patients face in maintaining clear near vision as they age.
References:1. Katz JA, Karpecki PM, Dorca A, et al. Presbyopia—a review of current treatment options and emerging therapies. Clin Ophthalmol. 2021;15:2167-2178. 2. Mancil GL, Baily IL, Brookman KE, et al. Optometric clinical practice guideline:care of the patient with presbyopia. American Optometric Association; 2011. 3. Brujic M, Kruger P, Todd J, et al. Living with presbyopia: experiences from a virtual roundtable dialogue among impacted individuals and healthcare professionals. BMC Ophthalmol. 2022;22:204. 4. Wolffsohn JS, Leteneux-Pantais C, Chiva-Razavi S, et al. Social media listening to understand the lived experience of presbyopia: systematic search and content analysis study. J Med Internet Res. 2020;22(9):e18306. 5. Grzybowski A, Kapitanovaite L, Zemaitiene R. An updated systematic review of pharmacological treatments for presbyopia. Adv Ophthalmol Pract Res. 2024;4(4):220-225.